Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03337009 · ClinicalTrials.gov registry record · NA

The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy

A NA study of Overdose and Risk Behavior, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
1,004
Enrollment target
1
Study location

NCT03337009 is a NA study of Overdose and Risk Behavior that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 1,004 participants, above the 188-participant average among 13 other Overdose trials with a reported enrollment target (434% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03337009, a NA study of Overdose and Risk Behavior, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,004 participants
Enrollment target
1
Study location

Study Summary

In the setting of naloxone standing orders, this study will assess the impact of a targeted, web-based overdose prevention and naloxone intervention for patients prescribed chronic opioid therapy. Outcomes are changes in opioid risk behaviors, naloxone uptake, and knowledge about overdose and naloxone.

Conditions Studied

Interventions

  • BEHAVIORAL Naloxone Navigator (NN)

Study Locations (1)

Colorado

  • Kaiser Permanente Colorado - Denver

Trial Details

FieldValue
Enrollment Target 1,004 participants
Start Date 2017-12-21
Est. Completion 2024-06-30
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT03337009

The ClinicalTrials.gov registry entry for NCT03337009 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,004 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 188-participant average among 13 other Overdose trials with a reported enrollment target (434% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Overdose appearing as the primary indexed condition, and to 1 intervention - of which Naloxone Navigator (NN) is the first listed.

NCT03337009 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03337009 about?

NCT03337009 is a clinical study titled "The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy". In the setting of naloxone standing orders, this study will assess the impact of a targeted, web-based overdose prevention and naloxone intervention for patients prescribed chronic opioid therapy. Outcomes are changes in opioid risk behaviors, naloxone uptake, and knowledge about overdose and naloxo...

What is the current status of trial NCT03337009?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,004 participants. The study started on 2017-12-21. Estimated completion is 2024-06-30.

What conditions does trial NCT03337009 study?

This clinical trial studies the following conditions: Overdose, Risk Behavior.

What interventions are being tested in trial NCT03337009?

The interventions under investigation include: Naloxone Navigator (NN) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03337009?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03337009 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overdose

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.